These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 11800205)

  • 21. A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders.
    Carpentier PJ; de Jong CA; Dijkstra BA; Verbrugge CA; Krabbe PF
    Addiction; 2005 Dec; 100(12):1868-74. PubMed ID: 16367988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Childhood stimulant treatment and risk for later substance abuse.
    Fischer M; Barkley RA
    J Clin Psychiatry; 2003; 64 Suppl 11():19-23. PubMed ID: 14529326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intranasal abuse of prescribed methylphenidate.
    Garland EJ
    J Am Acad Child Adolesc Psychiatry; 1998 Dec; 37(12):1242-3. PubMed ID: 9847492
    [No Abstract]   [Full Text] [Related]  

  • 24. Central auditory processing disorder and ADHD.
    Jerome L
    J Am Acad Child Adolesc Psychiatry; 2000 Apr; 39(4):399-400. PubMed ID: 10761339
    [No Abstract]   [Full Text] [Related]  

  • 25. A new long-acting methylphenidate (Concerta).
    Med Lett Drugs Ther; 2000 Sep; 42(1086):80-1. PubMed ID: 10980811
    [No Abstract]   [Full Text] [Related]  

  • 26. A drug to ease attention deficit-hyperactivity disorder.
    Smitherman CH
    MCN Am J Matern Child Nurs; 1990; 15(6):362-5. PubMed ID: 2124318
    [No Abstract]   [Full Text] [Related]  

  • 27. Use of methylphenidate for attention deficit hyperactivity disorder.
    Lexchin J
    CMAJ; 1991 May; 144(10):1209-10. PubMed ID: 2025813
    [No Abstract]   [Full Text] [Related]  

  • 28. Components of attention, methylphenidate dosage, and blood levels in children with attention deficit disorder.
    Sebrechts MM; Shaywitz SE; Shaywitz BA; Jatlow P; Anderson GM; Cohen DJ
    Pediatrics; 1986 Feb; 77(2):222-8. PubMed ID: 3945535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylphenidate revisited.
    Med Lett Drugs Ther; 1988 May; 30(765):51-2. PubMed ID: 3362094
    [No Abstract]   [Full Text] [Related]  

  • 30. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
    Adler LA; Zimmerman B; Starr HL; Silber S; Palumbo J; Orman C; Spencer T
    J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
    Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of extended release stimulant-based medications on neuropsychological functioning among adolescents with Attention-Deficit/Hyperactivity Disorder.
    Wilson HK; Cox DJ; Merkel RL; Moore M; Coghill D
    Arch Clin Neuropsychol; 2006 Dec; 21(8):797-807. PubMed ID: 17049803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do stimulants for ADHD lead to abuse later on?
    Child Health Alert; 2003 Feb; 21():1. PubMed ID: 12638512
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of methylphenidate for attention deficit hyperactivity disorder. Mental Health Committee, Canadian Paediatric Society.
    CMAJ; 1990 Apr; 142(8):817-8. PubMed ID: 2322913
    [No Abstract]   [Full Text] [Related]  

  • 35. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
    Research Units on Pediatric Psychopharmacology Autism Network
    Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder.
    Wilens TE; McBurnett K; Bukstein O; McGough J; Greenhill L; Lerner M; Stein MA; Conners CK; Duby J; Newcorn J; Bailey CE; Kratochvil CJ; Coury D; Casat C; Denisco MJ; Halstead P; Bloom L; Zimmerman BA; Gu J; Cooper KM; Lynch JM
    Arch Pediatr Adolesc Med; 2006 Jan; 160(1):82-90. PubMed ID: 16389216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Symposium: behavior modification by drugs. 3. The clinical use of stimulant drugs in children.
    Eisenberg L
    Pediatrics; 1972 May; 49(5):709-15. PubMed ID: 4504174
    [No Abstract]   [Full Text] [Related]  

  • 38. Carbamazepine and methylphenidate in ADHD.
    Schaller JL; Behar D
    J Am Acad Child Adolesc Psychiatry; 1999 Feb; 38(2):112-3. PubMed ID: 9951206
    [No Abstract]   [Full Text] [Related]  

  • 39. Attention deficit hyperactivity disorder and substance use disorders.
    Szobot CM; Bukstein O
    Child Adolesc Psychiatr Clin N Am; 2008 Apr; 17(2):309-23, viii. PubMed ID: 18295148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An adolescent who abruptly stops his medication for attention-deficit hyperactivity disorder.
    Stein MT; Shafer MA; Elliott GR; Levine S
    J Dev Behav Pediatr; 2001 Apr; 22(2 Suppl):S175-9. PubMed ID: 11332803
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.